These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20426189)

  • 1. Automated calibration for computerized analysis of prostate lesions using pharmacokinetic magnetic resonance images.
    Vos PC; Hambrock T; Barenstz JO; Huisman HJ
    Med Image Comput Comput Assist Interv; 2009; 12(Pt 2):836-43. PubMed ID: 20426189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation.
    Fennessy FM; Fedorov A; Penzkofer T; Kim KW; Hirsch MS; Vangel MG; Masry P; Flood TA; Chang MC; Tempany CM; Mulkern RV; Gupta SN
    Magn Reson Imaging; 2015 Sep; 33(7):886-94. PubMed ID: 25683515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
    Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
    AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computerized analysis of prostate lesions in the peripheral zone using dynamic contrast enhanced MRI.
    Vos PC; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; Barentsz JO; Huisman HJ
    Med Phys; 2008 Mar; 35(3):888-99. PubMed ID: 18404925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
    Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
    Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supervised and unsupervised methods for prostate cancer segmentation with multispectral MRI.
    Ozer S; Langer DL; Liu X; Haider MA; van der Kwast TH; Evans AJ; Yang Y; Wernick MN; Yetik IS
    Med Phys; 2010 Apr; 37(4):1873-83. PubMed ID: 20443509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-specific pharmacokinetic parameter estimation on dynamic contrast-enhanced MRI of prostate: Preliminary evaluation of a novel AIF-free estimation method.
    Ginsburg SB; Taimen P; Merisaari H; Vainio P; Boström PJ; Aronen HJ; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2016 Dec; 44(6):1405-1414. PubMed ID: 27285161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized Fast Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate: Effect of Sampling Duration on Pharmacokinetic Parameters.
    Othman AE; Falkner F; Martirosian P; Schraml C; Schwentner C; Nickel D; Nikolaou K; Notohamiprodjo M
    Invest Radiol; 2016 Feb; 51(2):106-12. PubMed ID: 26447494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automatic identification and classification of characteristic kinetic curves of breast lesions on DCE-MRI.
    Chen W; Giger ML; Bick U; Newstead GM
    Med Phys; 2006 Aug; 33(8):2878-87. PubMed ID: 16964864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
    Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
    J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided diagnosis of prostate cancer in the peripheral zone using multiparametric MRI.
    Niaf E; Rouvière O; Mège-Lechevallier F; Bratan F; Lartizien C
    Phys Med Biol; 2012 Jun; 57(12):3833-51. PubMed ID: 22640958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of prostate cancer using independent component analysis.
    Mehrabian H; Da Rosa M; Haider MA; Martel AL
    Magn Reson Imaging; 2015 Dec; 33(10):1236-1245. PubMed ID: 26297961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided diagnosis of breast DCE-MRI using pharmacokinetic model and 3-D morphology analysis.
    Wang TC; Huang YH; Huang CS; Chen JH; Huang GY; Chang YC; Chang RF
    Magn Reson Imaging; 2014 Apr; 32(3):197-205. PubMed ID: 24439361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed.
    Cui Y; Tan Y; Zhao B; Liberman L; Parbhu R; Kaplan J; Theodoulou M; Hudis C; Schwartz LH
    Med Phys; 2009 Oct; 36(10):4359-69. PubMed ID: 19928066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI.
    Vos PC; Hambrock T; Barenstz JO; Huisman HJ
    Phys Med Biol; 2010 Mar; 55(6):1719-34. PubMed ID: 20197602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-aided diagnosis for dynamic contrast-enhanced breast MRI of mass-like lesions using a multiparametric model combining a selection of morphological, kinetic, and spatiotemporal features.
    Agliozzo S; De Luca M; Bracco C; Vignati A; Giannini V; Martincich L; Carbonaro LA; Bert A; Sardanelli F; Regge D
    Med Phys; 2012 Apr; 39(4):1704-15. PubMed ID: 22482596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized breast lesions detection using kinetic and morphologic analysis for dynamic contrast-enhanced MRI.
    Chang YC; Huang YH; Huang CS; Chen JH; Chang RF
    Magn Reson Imaging; 2014 Jun; 32(5):514-22. PubMed ID: 24582545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fully automatic computer aided diagnosis system for peripheral zone prostate cancer detection using multi-parametric magnetic resonance imaging.
    Giannini V; Mazzetti S; Vignati A; Russo F; Bollito E; Porpiglia F; Stasi M; Regge D
    Comput Med Imaging Graph; 2015 Dec; 46 Pt 2():219-26. PubMed ID: 26391055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilevel analysis of spatiotemporal association features for differentiation of tumor enhancement patterns in breast DCE-MRI.
    Lee SH; Kim JH; Cho N; Park JS; Yang Z; Jung YS; Moon WK
    Med Phys; 2010 Aug; 37(8):3940-56. PubMed ID: 20879557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast enhanced MRI of the prostate: comparison of gadobutrol and Gd-DTPA.
    Durmus T; Vollnberg B; Schwenke C; Kilic E; Huppertz A; Taupitz M; Franiel T
    Rofo; 2013 Sep; 185(9):862-8. PubMed ID: 23888476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.